StockSelector.com
  Research, Select, & Monitor Saturday, February 23, 2019 8:23:24 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Corcept Therapeutics Inc.$11.40$.312.80%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Corcept Therapeutics Inc. vs Drug Delivery

Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.




Innovative companies whose purpose is to design and develop new ways to introduce drugs to the body. These new methods may consist of time-released capsules, differing injection techniques, or enabling certain drugs to be taken orally that may not have been to be taken so before. Their revenue is obtained from selling their technology to pharmaceutical companies or licensing it to manufacturers of prescription drugs.
 Totals Company Industry
  Sales: N/A $108,930.0 Mil
  Market Cap: $1,316.4 Mil $393,683.5 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
 Growth
  Historic Revenue: N/A 7.0%
  Estimated Revenue: N/A 4.8%
  Historic Earnings: N/A 10.4%
  Estimated Earnings: N/A 15.9%
  Stock Price (1 Year): (29.1%) 184.2%
  Cash per Share: N/A (7.0%)
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 14.1 17.4
  Price-to-Sales: N/A N/A
  Price-to-Book: N/A 3.0
  Dividend Yield: N/A N/A
  Market Cap: $1,316.4 Mil $30,283.3 Mil
  Operations
  Net Margin: N/A 7.9%
  Gross Margin: N/A 62.7%
  Return on Equity: N/A .1
  Return on Assets: N/A .0
  Balance Sheet
  Current Ratio: N/A 1.7
  Quick Ratio: N/A 1.1
  Cash Ratio: N/A .6
  Debt-to-Equity: N/A .8
  Interest Coverage: N/A 1.2
 Technicals
  Relative-Strength Index: 43.9 N/A

 Other companies in Drug Delivery Price Market Cap
  Roche Holding AG  (RHHBY) $34.73 $237,323.3 Mil
  Sanofi  (SNY) $41.18 $103,283.1 Mil
  Eisai Co Ltd  (ESALY) $80.78 $23,165.0 Mil
  Nektar Therapeutics  (NKTR) $40.05 $6,932.3 Mil
  Amarin Corporation plc  (AMRN) $19.87 $6,416.4 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.